See attached full report - a must read!
Valuation
We value Respiri at A$244m (A$0.37/share). Our base case is conservative and does not include US market entry. Our bull-case scenario, assigning 60% probability to a FY23 US market launch, yields a valuation of A$0.63/share.
Research Report, page-2
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $31.79M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.1¢ | 2.9¢ | $1.196K | 41.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 261265 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 217999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.1¢ |
Change
0.001 ( 6.90 %) |
||||
| Open | High | Low | Volume | ||
| 3.1¢ | 3.1¢ | 2.9¢ | 11369 | ||
| Last updated 15.59pm 15/05/2024 ? | |||||
| RSH (ASX) Chart |